2:20 PM
 | 
May 09, 2018
 |  BC Extra  |  Company News

Vir acquires antiviral gene-editing biotech Agenovir

Antiviral company Agenovir Corp. is now part of Vir Biotechnology Inc. (San Francisco, Calif.) under a "recent acquisition", according to a Vir spokesperson. Terms of the deal were unavailable through the Vir spokesperson.

Agenovir has developed CRISPR-based...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >